Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00527202Phase 4Completed
A Phase 4 trial of botulinum toxin type A in postherpetic neuralgia (PHN), traumatic nerve injury (PNI), sponsored by Hôpital Ambroise-Paré. Started Jun 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00527202.